#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=Frederick Frank ( businessman )
1-1	0-9	Frederick	person[1]	new[1]	appos	1-4[0_1]
1-2	10-15	Frank	person[1]	new[1]	_	_
1-3	16-17	(	_	_	_	_
1-4	18-29	businessman	person	giv	coref	2-1[3_0]
1-5	30-31	)	_	_	_	_

#Text=Frederick Frank ( born May 31 , 1932 , Salt Lake City , Utah ) is an investment banker , with more than 50 years of experience on Wall Street .
2-1	32-41	Frederick	person[3]	giv[3]	coref	2-17[8_3]
2-2	42-47	Frank	person[3]	giv[3]	_	_
2-3	48-49	(	person[3]	giv[3]	_	_
2-4	50-54	born	person[3]	giv[3]	_	_
2-5	55-58	May	person[3]|time[4]	giv[3]|new[4]	coref	9-6[53_4]
2-6	59-61	31	person[3]|time[4]	giv[3]|new[4]	_	_
2-7	62-63	,	person[3]|time[4]	giv[3]|new[4]	_	_
2-8	64-68	1932	person[3]|time[4]|time	giv[3]|new[4]|new	coref	9-9
2-9	69-70	,	_	_	_	_
2-10	71-75	Salt	place[6]	new[6]	coref	9-24[60_6]
2-11	76-80	Lake	place[6]	new[6]	_	_
2-12	81-85	City	place[6]	new[6]	_	_
2-13	86-87	,	place[6]	new[6]	_	_
2-14	88-92	Utah	place[6]	new[6]	_	_
2-15	93-94	)	_	_	_	_
2-16	95-97	is	_	_	_	_
2-17	98-100	an	person[8]	giv[8]	ana	3-1[0_8]
2-18	101-111	investment	abstract|person[8]	new|giv[8]	coref	3-6
2-19	112-118	banker	person[8]	giv[8]	_	_
2-20	119-120	,	person[8]	giv[8]	_	_
2-21	121-125	with	person[8]	giv[8]	_	_
2-22	126-130	more	person[8]|time[9]	giv[8]|new[9]	_	_
2-23	131-135	than	person[8]|time[9]	giv[8]|new[9]	_	_
2-24	136-138	50	person[8]|time[9]	giv[8]|new[9]	_	_
2-25	139-144	years	person[8]|time[9]	giv[8]|new[9]	_	_
2-26	145-147	of	person[8]|time[9]	giv[8]|new[9]	_	_
2-27	148-158	experience	person[8]|time[9]|abstract[10]	giv[8]|new[9]|new[10]	_	_
2-28	159-161	on	person[8]|time[9]|abstract[10]	giv[8]|new[9]|new[10]	_	_
2-29	162-166	Wall	person[8]|time[9]|abstract[10]|place[11]	giv[8]|new[9]|new[10]|new[11]	coref	19-11[125_11]
2-30	167-173	Street	person[8]|time[9]|abstract[10]|place[11]	giv[8]|new[9]|new[10]|new[11]	_	_
2-31	174-175	.	_	_	_	_

#Text=He is considered the first investment banker to have specialized in the areas of biotechnology , pharmaceuticals , and health care services . [ 4 ] [ 5 ]
3-1	176-178	He	person	giv	coref	3-4[14_0]
3-2	179-181	is	_	_	_	_
3-3	182-192	considered	_	_	_	_
3-4	193-196	the	person[14]	giv[14]	coref	4-5[0_14]
3-5	197-202	first	person[14]	giv[14]	_	_
3-6	203-213	investment	abstract|person[14]	giv|giv[14]	coref	23-13[166_0]
3-7	214-220	banker	person[14]	giv[14]	_	_
3-8	221-223	to	person[14]	giv[14]	_	_
3-9	224-228	have	person[14]	giv[14]	_	_
3-10	229-240	specialized	person[14]	giv[14]	_	_
3-11	241-243	in	person[14]	giv[14]	_	_
3-12	244-247	the	person[14]|abstract[15]	giv[14]|new[15]	coref	19-5[124_15]
3-13	248-253	areas	person[14]|abstract[15]	giv[14]|new[15]	_	_
3-14	254-256	of	person[14]|abstract[15]	giv[14]|new[15]	_	_
3-15	257-270	biotechnology	person[14]|abstract[15]|abstract	giv[14]|new[15]|new	coref	7-12
3-16	271-272	,	person[14]|abstract[15]	giv[14]|new[15]	_	_
3-17	273-288	pharmaceuticals	person[14]|abstract[15]|substance	giv[14]|new[15]|new	coref	19-19
3-18	289-290	,	person[14]|abstract[15]	giv[14]|new[15]	_	_
3-19	291-294	and	person[14]|abstract[15]	giv[14]|new[15]	_	_
3-20	295-301	health	person[14]|abstract[15]|abstract[18]|abstract[19]	giv[14]|new[15]|new[18]|new[19]	coref	20-22[138_19]
3-21	302-306	care	person[14]|abstract[15]|abstract[18]|abstract[19]	giv[14]|new[15]|new[18]|new[19]	_	_
3-22	307-315	services	person[14]|abstract[15]|abstract[19]	giv[14]|new[15]|new[19]	_	_
3-23	316-317	.	_	_	_	_
3-24	318-319	[	_	_	_	_
3-25	320-321	4	abstract	new	coref	5-22
3-26	322-323	]	_	_	_	_
3-27	324-325	[	_	_	_	_
3-28	326-327	5	abstract	new	coref	7-17
3-29	328-329	]	_	_	_	_

#Text=As of 2014 , Frank became a founder and chair of EVOLUTION Life Science Partners .
4-1	330-332	As	_	_	_	_
4-2	333-335	of	_	_	_	_
4-3	336-340	2014	time	new	_	_
4-4	341-342	,	_	_	_	_
4-5	343-348	Frank	person	giv	ana	5-1
4-6	349-355	became	_	_	_	_
4-7	356-357	a	_	_	_	_
4-8	358-365	founder	_	_	_	_
4-9	366-369	and	_	_	_	_
4-10	370-375	chair	_	_	_	_
4-11	376-378	of	_	_	_	_
4-12	379-388	EVOLUTION	organization|organization[27]	new|new[27]	coref|coref	45-9|45-9[323_27]
4-13	389-393	Life	person|organization[26]|organization[27]	new|new[26]|new[27]	coref|coref	45-10|45-9[322_26]
4-14	394-401	Science	organization[26]|organization[27]	new[26]|new[27]	_	_
4-15	402-410	Partners	organization[27]	new[27]	_	_
4-16	411-412	.	_	_	_	_

#Text=He previously served as vice chairman of Lehman Brothers , Barclays Capital , and the Peter J. Solomon Company . [ 4 ]
5-1	413-415	He	person	giv	ana	6-1
5-2	416-426	previously	_	_	_	_
5-3	427-433	served	_	_	_	_
5-4	434-436	as	_	_	_	_
5-5	437-441	vice	person[29]	new[29]	_	_
5-6	442-450	chairman	person[29]	new[29]	_	_
5-7	451-453	of	person[29]	new[29]	_	_
5-8	454-460	Lehman	person[29]|person[30]	new[29]|new[30]	coref	22-11[0_30]
5-9	461-469	Brothers	person[29]|person[30]	new[29]|new[30]	_	_
5-10	470-471	,	person[29]	new[29]	_	_
5-11	472-480	Barclays	person[29]|organization|organization[32]	new[29]|new|new[32]	coref|coref	38-2|38-2[257_32]
5-12	481-488	Capital	person[29]|organization[32]	new[29]|new[32]	_	_
5-13	489-490	,	_	_	_	_
5-14	491-494	and	_	_	_	_
5-15	495-498	the	organization[34]	new[34]	coref	16-10[0_34]
5-16	499-504	Peter	person[33]|organization[34]	new[33]|new[34]	coref	40-14[276_33]
5-17	505-507	J.	person[33]|organization[34]	new[33]|new[34]	_	_
5-18	508-515	Solomon	person[33]|organization[34]	new[33]|new[34]	_	_
5-19	516-523	Company	organization[34]	new[34]	_	_
5-20	524-525	.	_	_	_	_
5-21	526-527	[	_	_	_	_
5-22	528-529	4	abstract	giv	coref	45-23
5-23	530-531	]	_	_	_	_

#Text=He is credited as lead underwriter for over 125 IPOs and as a negotiator in over 75 mergers and acquisitions . [ 6 ]
6-1	532-534	He	person	giv	coref	7-1
6-2	535-537	is	_	_	_	_
6-3	538-546	credited	_	_	_	_
6-4	547-549	as	_	_	_	_
6-5	550-554	lead	person[37]	new[37]	_	_
6-6	555-566	underwriter	person[37]	new[37]	_	_
6-7	567-570	for	person[37]	new[37]	_	_
6-8	571-575	over	person[37]|organization[38]	new[37]|new[38]	_	_
6-9	576-579	125	person[37]|organization[38]	new[37]|new[38]	_	_
6-10	580-584	IPOs	person[37]|organization[38]	new[37]|new[38]	_	_
6-11	585-588	and	_	_	_	_
6-12	589-591	as	_	_	_	_
6-13	592-593	a	person[39]	new[39]	_	_
6-14	594-604	negotiator	person[39]	new[39]	_	_
6-15	605-607	in	person[39]	new[39]	_	_
6-16	608-612	over	person[39]|event[40]	new[39]|new[40]	coref	23-16[0_40]
6-17	613-615	75	person[39]|event[40]	new[39]|new[40]	_	_
6-18	616-623	mergers	person[39]|event[40]	new[39]|new[40]	_	_
6-19	624-627	and	person[39]	new[39]	_	_
6-20	628-640	acquisitions	person[39]|event	new[39]|new	coref	23-18
6-21	641-642	.	_	_	_	_
6-22	643-644	[	_	_	_	_
6-23	645-646	6	abstract	new	_	_
6-24	647-648	]	_	_	_	_

#Text=Frank was chosen as one of the top 100 contributors to biotechnology in 2005 . [ 5 ] [ 7 ]
7-1	649-654	Frank	person	giv	coref	9-1[52_0]
7-2	655-658	was	_	_	_	_
7-3	659-665	chosen	_	_	_	_
7-4	666-668	as	_	_	_	_
7-5	669-672	one	person[44]	new[44]	_	_
7-6	673-675	of	person[44]	new[44]	_	_
7-7	676-679	the	person[44]|person[45]	new[44]|new[45]	_	_
7-8	680-683	top	person[44]|person[45]	new[44]|new[45]	_	_
7-9	684-687	100	person[44]|person[45]	new[44]|new[45]	_	_
7-10	688-700	contributors	person[44]|person[45]	new[44]|new[45]	_	_
7-11	701-703	to	person[44]|person[45]	new[44]|new[45]	_	_
7-12	704-717	biotechnology	person[44]|person[45]|abstract	new[44]|new[45]|giv	_	_
7-13	718-720	in	_	_	_	_
7-14	721-725	2005	time	new	_	_
7-15	726-727	.	_	_	_	_
7-16	728-729	[	_	_	_	_
7-17	730-731	5	abstract	giv	coref	21-21
7-18	732-733	]	_	_	_	_
7-19	734-735	[	_	_	_	_
7-20	736-737	7	abstract	new	_	_
7-21	738-739	]	_	_	_	_

#Text=Early life and education
8-1	740-745	Early	abstract[50]	new[50]	coref	20-9[0_50]
8-2	746-750	life	abstract[50]	new[50]	_	_
8-3	751-754	and	_	_	_	_
8-4	755-764	education	abstract	new	_	_

#Text=Frederick Frank was born on May 31 , 1932 , [ 8 ] to Simon Frank and Suzanne ( Seller ) Frank of Salt Lake City , Utah .
9-1	765-774	Frederick	person[52]	giv[52]	coref	9-15[56_52]
9-2	775-780	Frank	person[52]	giv[52]	_	_
9-3	781-784	was	_	_	_	_
9-4	785-789	born	_	_	_	_
9-5	790-792	on	_	_	_	_
9-6	793-796	May	time[53]	giv[53]	_	_
9-7	797-799	31	time[53]	giv[53]	_	_
9-8	800-801	,	time[53]	giv[53]	_	_
9-9	802-806	1932	time[53]|time	giv[53]|giv	_	_
9-10	807-808	,	_	_	_	_
9-11	809-810	[	_	_	_	_
9-12	811-812	8	abstract	new	coref	11-16
9-13	813-814	]	_	_	_	_
9-14	815-817	to	_	_	_	_
9-15	818-823	Simon	person[56]|person[57]	giv[56]|giv[57]	coref|coref	9-15[57_56]|12-1[0_57]
9-16	824-829	Frank	person[56]|person[57]	giv[56]|giv[57]	_	_
9-17	830-833	and	person[57]	giv[57]	_	_
9-18	834-841	Suzanne	person[57]|person	giv[57]|new	appos	9-20
9-19	842-843	(	_	_	_	_
9-20	844-850	Seller	person	giv	ana	10-1
9-21	851-852	)	_	_	_	_
9-22	853-858	Frank	_	_	_	_
9-23	859-861	of	_	_	_	_
9-24	862-866	Salt	place[60]	giv[60]	coref	48-13[338_60]
9-25	867-871	Lake	place[60]	giv[60]	_	_
9-26	872-876	City	place[60]	giv[60]	_	_
9-27	877-878	,	place[60]	giv[60]	_	_
9-28	879-883	Utah	place[60]	giv[60]	_	_
9-29	884-885	.	_	_	_	_

#Text=He ran a men 's wear business established by his father , Arthur Frank . [ 9 ]
10-1	886-888	He	person	giv	coref	10-4[62_0]
10-2	889-892	ran	_	_	_	_
10-3	893-894	a	organization[64]	new[64]	_	_
10-4	895-898	men	person[62]|organization[64]	giv[62]|new[64]	ana	10-10[0_62]
10-5	899-901	's	person[62]|organization[64]	giv[62]|new[64]	_	_
10-6	902-906	wear	abstract|organization[64]	new|new[64]	_	_
10-7	907-915	business	organization[64]	new[64]	_	_
10-8	916-927	established	organization[64]	new[64]	_	_
10-9	928-930	by	organization[64]	new[64]	_	_
10-10	931-934	his	organization[64]|person|person[66]	new[64]|giv|new[66]	appos|ana	10-13[67_66]|11-1
10-11	935-941	father	organization[64]|person[66]	new[64]|new[66]	_	_
10-12	942-943	,	_	_	_	_
10-13	944-950	Arthur	person[67]	giv[67]	_	_
10-14	951-956	Frank	person[67]	giv[67]	_	_
10-15	957-958	.	_	_	_	_
10-16	959-960	[	_	_	_	_
10-17	961-962	9	abstract	new	_	_
10-18	963-964	]	_	_	_	_

#Text=He completed high school at Hotchkiss School in Lakeville , Connecticut in 1950 . [ 8 ] [ 10 ] [ 3 ]
11-1	965-967	He	person	giv	_	_
11-2	968-977	completed	_	_	_	_
11-3	978-982	high	organization[70]	new[70]	_	_
11-4	983-989	school	organization[70]	new[70]	_	_
11-5	990-992	at	_	_	_	_
11-6	993-1002	Hotchkiss	person|organization[72]	new|new[72]	coref	14-13[99_72]
11-7	1003-1009	School	organization[72]	new[72]	_	_
11-8	1010-1012	in	organization[72]	new[72]	_	_
11-9	1013-1022	Lakeville	organization[72]|place[73]	new[72]|new[73]	_	_
11-10	1023-1024	,	organization[72]|place[73]	new[72]|new[73]	_	_
11-11	1025-1036	Connecticut	organization[72]|place[73]|place	new[72]|new[73]|new	_	_
11-12	1037-1039	in	_	_	_	_
11-13	1040-1044	1950	time	new	_	_
11-14	1045-1046	.	_	_	_	_
11-15	1047-1048	[	_	_	_	_
11-16	1049-1050	8	abstract	giv	coref	13-31
11-17	1051-1052	]	_	_	_	_
11-18	1053-1054	[	_	_	_	_
11-19	1055-1057	10	abstract	new	coref	14-22
11-20	1058-1059	]	_	_	_	_
11-21	1060-1061	[	_	_	_	_
11-22	1062-1063	3	abstract	new	coref	28-16
11-23	1064-1065	]	_	_	_	_

#Text=Frank graduated in the class of 1954 from Yale University with a degree in philosophy . [ 11 ]
12-1	1066-1071	Frank	person	giv	coref	16-4
12-2	1072-1081	graduated	_	_	_	_
12-3	1082-1084	in	_	_	_	_
12-4	1085-1088	the	person[80]	new[80]	ana	13-1[0_80]
12-5	1089-1094	class	person[80]	new[80]	_	_
12-6	1095-1097	of	person[80]	new[80]	_	_
12-7	1098-1102	1954	person[80]|time	new[80]|new	coref	52-18
12-8	1103-1107	from	_	_	_	_
12-9	1108-1112	Yale	organization[82]	new[82]	coref	26-12[187_82]
12-10	1113-1123	University	organization[82]	new[82]	_	_
12-11	1124-1128	with	_	_	_	_
12-12	1129-1130	a	abstract[83]	new[83]	_	_
12-13	1131-1137	degree	abstract[83]	new[83]	_	_
12-14	1138-1140	in	abstract[83]	new[83]	_	_
12-15	1141-1151	philosophy	abstract[83]|abstract	new[83]|new	_	_
12-16	1152-1153	.	_	_	_	_
12-17	1154-1155	[	_	_	_	_
12-18	1156-1158	11	abstract	new	coref	29-12
12-19	1159-1160	]	_	_	_	_

#Text=He served in the U.S. Army in Europe from 1954-1956 , much of the time in Paris , France at Supreme Headquarters Allied Powers Europe ( SHAPE ) . [ 8 ]
13-1	1161-1163	He	person	giv	ana	14-8
13-2	1164-1170	served	_	_	_	_
13-3	1171-1173	in	_	_	_	_
13-4	1174-1177	the	organization[87]	new[87]	_	_
13-5	1178-1182	U.S.	organization[87]	new[87]	_	_
13-6	1183-1187	Army	organization[87]	new[87]	_	_
13-7	1188-1190	in	_	_	_	_
13-8	1191-1197	Europe	place	new	_	_
13-9	1198-1202	from	_	_	_	_
13-10	1203-1212	1954-1956	time	new	coref	13-14[90_0]
13-11	1213-1214	,	_	_	_	_
13-12	1215-1219	much	_	_	_	_
13-13	1220-1222	of	_	_	_	_
13-14	1223-1226	the	time[90]	giv[90]	_	_
13-15	1227-1231	time	time[90]	giv[90]	_	_
13-16	1232-1234	in	_	_	_	_
13-17	1235-1240	Paris	place[91]	new[91]	_	_
13-18	1241-1242	,	place[91]	new[91]	_	_
13-19	1243-1249	France	place[91]	new[91]	_	_
13-20	1250-1252	at	_	_	_	_
13-21	1253-1260	Supreme	place[92]	new[92]	_	_
13-22	1261-1273	Headquarters	place[92]	new[92]	_	_
13-23	1274-1280	Allied	person[93]	new[93]	_	_
13-24	1281-1287	Powers	person[93]	new[93]	_	_
13-25	1288-1294	Europe	person[93]	new[93]	_	_
13-26	1295-1296	(	_	_	_	_
13-27	1297-1302	SHAPE	organization	new	_	_
13-28	1303-1304	)	_	_	_	_
13-29	1305-1306	.	_	_	_	_
13-30	1307-1308	[	_	_	_	_
13-31	1309-1310	8	abstract	giv	_	_
13-32	1311-1312	]	_	_	_	_

#Text=After returning to the United States , he received an MBA from Stanford Graduate School of Business in 1958 . [ 10 ] [ 12 ]
14-1	1313-1318	After	_	_	_	_
14-2	1319-1328	returning	_	_	_	_
14-3	1329-1331	to	_	_	_	_
14-4	1332-1335	the	place[96]	new[96]	_	_
14-5	1336-1342	United	place[96]	new[96]	_	_
14-6	1343-1349	States	place[96]	new[96]	_	_
14-7	1350-1351	,	_	_	_	_
14-8	1352-1354	he	person	giv	_	_
14-9	1355-1363	received	_	_	_	_
14-10	1364-1366	an	abstract[98]	new[98]	_	_
14-11	1367-1370	MBA	abstract[98]	new[98]	_	_
14-12	1371-1375	from	_	_	_	_
14-13	1376-1384	Stanford	organization[99]	giv[99]	_	_
14-14	1385-1393	Graduate	organization[99]	giv[99]	_	_
14-15	1394-1400	School	organization[99]	giv[99]	_	_
14-16	1401-1403	of	organization[99]	giv[99]	_	_
14-17	1404-1412	Business	organization[99]	giv[99]	_	_
14-18	1413-1415	in	_	_	_	_
14-19	1416-1420	1958	time	new	coref	16-2
14-20	1421-1422	.	_	_	_	_
14-21	1423-1424	[	_	_	_	_
14-22	1425-1427	10	abstract	giv	_	_
14-23	1428-1429	]	_	_	_	_
14-24	1430-1431	[	_	_	_	_
14-25	1432-1434	12	abstract	new	coref	20-26
14-26	1435-1436	]	_	_	_	_

#Text=Career
15-1	1437-1443	Career	abstract	new	_	_

#Text=In 1958 , Frank joined Smith , Barney and Company .
16-1	1444-1446	In	_	_	_	_
16-2	1447-1451	1958	time	giv	_	_
16-3	1452-1453	,	_	_	_	_
16-4	1454-1459	Frank	person	giv	coref	18-9
16-5	1460-1466	joined	_	_	_	_
16-6	1467-1472	Smith	organization|person[107]	new|new[107]	ana|coref	17-5[0_107]|21-16
16-7	1473-1474	,	person[107]	new[107]	_	_
16-8	1475-1481	Barney	person[107]|person	new[107]|new	ana	17-1
16-9	1482-1485	and	person[107]	new[107]	_	_
16-10	1486-1493	Company	person[107]|organization	new[107]|giv	coref	43-16[305_0]
16-11	1494-1495	.	_	_	_	_

#Text=He chose to accept their offer because they had a highly ranked research department .
17-1	1496-1498	He	person	giv	coref	21-18
17-2	1499-1504	chose	_	_	_	_
17-3	1505-1507	to	_	_	_	_
17-4	1508-1514	accept	_	_	_	_
17-5	1515-1520	their	person|abstract[112]	giv|new[112]	ana	17-8
17-6	1521-1526	offer	abstract[112]	new[112]	_	_
17-7	1527-1534	because	_	_	_	_
17-8	1535-1539	they	person	giv	_	_
17-9	1540-1543	had	_	_	_	_
17-10	1544-1545	a	organization[115]	new[115]	coref	18-11[120_115]
17-11	1546-1552	highly	organization[115]	new[115]	_	_
17-12	1553-1559	ranked	organization[115]	new[115]	_	_
17-13	1560-1568	research	abstract|organization[115]	new|new[115]	coref	18-12
17-14	1569-1579	department	organization[115]	new[115]	_	_
17-15	1580-1581	.	_	_	_	_

#Text=After completing the required formal training program , Frank joined the research department to work with Bill Grant on the pharmaceutical and chemical industries .
18-1	1582-1587	After	_	_	_	_
18-2	1588-1598	completing	_	_	_	_
18-3	1599-1602	the	abstract[117]	new[117]	_	_
18-4	1603-1611	required	abstract[117]	new[117]	_	_
18-5	1612-1618	formal	abstract[117]	new[117]	_	_
18-6	1619-1627	training	abstract|abstract[117]	new|new[117]	_	_
18-7	1628-1635	program	abstract[117]	new[117]	_	_
18-8	1636-1637	,	_	_	_	_
18-9	1638-1643	Frank	person	giv	coref	22-5
18-10	1644-1650	joined	_	_	_	_
18-11	1651-1654	the	organization[120]	giv[120]	_	_
18-12	1655-1663	research	abstract|organization[120]	giv|giv[120]	coref	21-8
18-13	1664-1674	department	organization[120]	giv[120]	_	_
18-14	1675-1677	to	_	_	_	_
18-15	1678-1682	work	_	_	_	_
18-16	1683-1687	with	_	_	_	_
18-17	1688-1692	Bill	person[121]	new[121]	ana	19-1[0_121]
18-18	1693-1698	Grant	person[121]	new[121]	_	_
18-19	1699-1701	on	_	_	_	_
18-20	1702-1705	the	abstract[122]	new[122]	coref	20-8[133_122]
18-21	1706-1720	pharmaceutical	abstract[122]	new[122]	_	_
18-22	1721-1724	and	abstract[122]	new[122]	_	_
18-23	1725-1733	chemical	abstract[122]	new[122]	_	_
18-24	1734-1744	industries	abstract[122]	new[122]	_	_
18-25	1745-1746	.	_	_	_	_

#Text=He soon proposed splitting the two areas , and became Wall Street ’s first industry analyst dedicated to pharmaceuticals .
19-1	1747-1749	He	person	giv	ana	20-4
19-2	1750-1754	soon	_	_	_	_
19-3	1755-1763	proposed	_	_	_	_
19-4	1764-1773	splitting	_	_	_	_
19-5	1774-1777	the	abstract[124]	giv[124]	_	_
19-6	1778-1781	two	abstract[124]	giv[124]	_	_
19-7	1782-1787	areas	abstract[124]	giv[124]	_	_
19-8	1788-1789	,	_	_	_	_
19-9	1790-1793	and	_	_	_	_
19-10	1794-1800	became	_	_	_	_
19-11	1801-1805	Wall	place[125]	giv[125]	_	_
19-12	1806-1812	Street	place[125]	giv[125]	_	_
19-13	1813-1815	’s	place[125]	giv[125]	_	_
19-14	1816-1821	first	_	_	_	_
19-15	1822-1830	industry	abstract	new	_	_
19-16	1831-1838	analyst	_	_	_	_
19-17	1839-1848	dedicated	_	_	_	_
19-18	1849-1851	to	_	_	_	_
19-19	1852-1867	pharmaceuticals	substance	giv	_	_
19-20	1868-1869	.	_	_	_	_

#Text=In 1962 , he shifted focus to the life sciences industries , dealing with medical devices , diagnostics companies , and healthcare services . [ 12 ]
20-1	1870-1872	In	_	_	_	_
20-2	1873-1877	1962	time	new	_	_
20-3	1878-1879	,	_	_	_	_
20-4	1880-1882	he	person	giv	ana	21-1
20-5	1883-1890	shifted	_	_	_	_
20-6	1891-1896	focus	abstract	new	_	_
20-7	1897-1899	to	_	_	_	_
20-8	1900-1903	the	abstract[133]	giv[133]	_	_
20-9	1904-1908	life	abstract|abstract[132]|abstract[133]	giv|new[132]|giv[133]	coref|coref	40-30|40-30[281_132]
20-10	1909-1917	sciences	abstract[132]|abstract[133]	new[132]|giv[133]	_	_
20-11	1918-1928	industries	abstract[133]	giv[133]	_	_
20-12	1929-1930	,	_	_	_	_
20-13	1931-1938	dealing	_	_	_	_
20-14	1939-1943	with	_	_	_	_
20-15	1944-1951	medical	object[134]	new[134]	_	_
20-16	1952-1959	devices	object[134]	new[134]	_	_
20-17	1960-1961	,	_	_	_	_
20-18	1962-1973	diagnostics	abstract|organization[136]	new|new[136]	coref	24-15[172_136]
20-19	1974-1983	companies	organization[136]	new[136]	_	_
20-20	1984-1985	,	_	_	_	_
20-21	1986-1989	and	_	_	_	_
20-22	1990-2000	healthcare	organization|abstract[138]	new|giv[138]	_	_
20-23	2001-2009	services	abstract[138]	giv[138]	_	_
20-24	2010-2011	.	_	_	_	_
20-25	2012-2013	[	_	_	_	_
20-26	2014-2016	12	abstract	giv	coref	21-24
20-27	2017-2018	]	_	_	_	_

#Text=He held the positions of co-leader of research , vice president , and director at Smith , Barney . [ 5 ] [ 12 ]
21-1	2019-2021	He	person	giv	_	_
21-2	2022-2026	held	_	_	_	_
21-3	2027-2030	the	abstract[141]	new[141]	_	_
21-4	2031-2040	positions	abstract[141]	new[141]	_	_
21-5	2041-2043	of	abstract[141]	new[141]	_	_
21-6	2044-2053	co-leader	abstract[141]|person[142]|person[143]	new[141]|new[142]|new[143]	ana	28-11[0_143]
21-7	2054-2056	of	abstract[141]|person[142]|person[143]	new[141]|new[142]|new[143]	_	_
21-8	2057-2065	research	abstract[141]|person[142]|person[143]|abstract	new[141]|new[142]|new[143]|giv	coref	23-2
21-9	2066-2067	,	abstract[141]|person[143]	new[141]|new[143]	_	_
21-10	2068-2072	vice	abstract[141]|person[143]|person[145]	new[141]|new[143]|new[145]	_	_
21-11	2073-2082	president	abstract[141]|person[143]|person[145]	new[141]|new[143]|new[145]	_	_
21-12	2083-2084	,	abstract[141]|person[143]	new[141]|new[143]	_	_
21-13	2085-2088	and	abstract[141]|person[143]	new[141]|new[143]	_	_
21-14	2089-2097	director	abstract[141]|person[143]|person	new[141]|new[143]|new	_	_
21-15	2098-2100	at	_	_	_	_
21-16	2101-2106	Smith	organization	giv	coref	22-7[154_0]
21-17	2107-2108	,	_	_	_	_
21-18	2109-2115	Barney	person	giv	_	_
21-19	2116-2117	.	_	_	_	_
21-20	2118-2119	[	_	_	_	_
21-21	2120-2121	5	abstract	giv	coref	57-13
21-22	2122-2123	]	_	_	_	_
21-23	2124-2125	[	_	_	_	_
21-24	2126-2128	12	abstract	giv	coref	24-28
21-25	2129-2130	]	_	_	_	_

#Text=In October 1969 , Frank left Smith Barney and joined Lehman Brothers , the first person from outside the organization to join it at the level of partner .
22-1	2131-2133	In	_	_	_	_
22-2	2134-2141	October	time	new	coref	48-3[333_0]
22-3	2142-2146	1969	time	new	_	_
22-4	2147-2148	,	_	_	_	_
22-5	2149-2154	Frank	person	giv	coref	24-1
22-6	2155-2159	left	_	_	_	_
22-7	2160-2165	Smith	organization[154]	giv[154]	coref	22-19[158_154]
22-8	2166-2172	Barney	organization[154]	giv[154]	_	_
22-9	2173-2176	and	_	_	_	_
22-10	2177-2183	joined	_	_	_	_
22-11	2184-2190	Lehman	person	giv	coref	22-12
22-12	2191-2199	Brothers	person	giv	appos	22-14[157_0]
22-13	2200-2201	,	_	_	_	_
22-14	2202-2205	the	person[157]	giv[157]	ana	23-6[0_157]
22-15	2206-2211	first	person[157]	giv[157]	_	_
22-16	2212-2218	person	person[157]	giv[157]	_	_
22-17	2219-2223	from	person[157]	giv[157]	_	_
22-18	2224-2231	outside	person[157]	giv[157]	_	_
22-19	2232-2235	the	person[157]|organization[158]	giv[157]|giv[158]	ana	22-23[0_158]
22-20	2236-2248	organization	person[157]|organization[158]	giv[157]|giv[158]	_	_
22-21	2249-2251	to	person[157]	giv[157]	_	_
22-22	2252-2256	join	person[157]	giv[157]	_	_
22-23	2257-2259	it	person[157]|organization	giv[157]|giv	_	_
22-24	2260-2262	at	person[157]	giv[157]	_	_
22-25	2263-2266	the	person[157]|abstract[160]	giv[157]|new[160]	_	_
22-26	2267-2272	level	person[157]|abstract[160]	giv[157]|new[160]	_	_
22-27	2273-2275	of	person[157]|abstract[160]	giv[157]|new[160]	_	_
22-28	2276-2283	partner	person[157]|abstract[160]|person	giv[157]|new[160]|new	_	_
22-29	2284-2285	.	_	_	_	_

#Text=Leaving research and analysis , he shifted to investment banking , handling capital investment and mergers and acquisitions .
23-1	2286-2293	Leaving	_	_	_	_
23-2	2294-2302	research	abstract	giv	_	_
23-3	2303-2306	and	_	_	_	_
23-4	2307-2315	analysis	abstract	new	_	_
23-5	2316-2317	,	_	_	_	_
23-6	2318-2320	he	person	giv	coref	25-9
23-7	2321-2328	shifted	_	_	_	_
23-8	2329-2331	to	_	_	_	_
23-9	2332-2342	investment	abstract[165]	new[165]	_	_
23-10	2343-2350	banking	abstract[165]	new[165]	_	_
23-11	2351-2352	,	_	_	_	_
23-12	2353-2361	handling	_	_	_	_
23-13	2362-2369	capital	abstract[166]	giv[166]	_	_
23-14	2370-2380	investment	abstract[166]	giv[166]	_	_
23-15	2381-2384	and	_	_	_	_
23-16	2385-2392	mergers	event	giv	_	_
23-17	2393-2396	and	_	_	_	_
23-18	2397-2409	acquisitions	event	giv	_	_
23-19	2410-2411	.	_	_	_	_

#Text=Frank is credited with creating original and at times unprecedented structures that have connected innovative early-stage research-oriented companies with larger development and market-oriented pharmaceutical corporations . [ 12 ]
24-1	2412-2417	Frank	person	giv	coref	25-4
24-2	2418-2420	is	_	_	_	_
24-3	2421-2429	credited	_	_	_	_
24-4	2430-2434	with	_	_	_	_
24-5	2435-2443	creating	_	_	_	_
24-6	2444-2452	original	abstract[171]	new[171]	_	_
24-7	2453-2456	and	abstract[171]	new[171]	_	_
24-8	2457-2459	at	abstract[171]	new[171]	_	_
24-9	2460-2465	times	time|abstract[171]	new|new[171]	_	_
24-10	2466-2479	unprecedented	abstract[171]	new[171]	_	_
24-11	2480-2490	structures	abstract[171]	new[171]	_	_
24-12	2491-2495	that	abstract[171]	new[171]	_	_
24-13	2496-2500	have	abstract[171]	new[171]	_	_
24-14	2501-2510	connected	abstract[171]	new[171]	_	_
24-15	2511-2521	innovative	abstract[171]|organization[172]	new[171]|giv[172]	coref	32-11[217_172]
24-16	2522-2533	early-stage	abstract[171]|organization[172]	new[171]|giv[172]	_	_
24-17	2534-2551	research-oriented	abstract[171]|organization[172]	new[171]|giv[172]	_	_
24-18	2552-2561	companies	abstract[171]|organization[172]	new[171]|giv[172]	_	_
24-19	2562-2566	with	abstract[171]	new[171]	_	_
24-20	2567-2573	larger	abstract[171]|organization[174]	new[171]|new[174]	_	_
24-21	2574-2585	development	abstract[171]|abstract|organization[174]	new[171]|new|new[174]	_	_
24-22	2586-2589	and	abstract[171]|organization[174]	new[171]|new[174]	_	_
24-23	2590-2605	market-oriented	abstract[171]|organization[174]	new[171]|new[174]	_	_
24-24	2606-2620	pharmaceutical	abstract[171]|organization[174]	new[171]|new[174]	_	_
24-25	2621-2633	corporations	abstract[171]|organization[174]	new[171]|new[174]	_	_
24-26	2634-2635	.	_	_	_	_
24-27	2636-2637	[	_	_	_	_
24-28	2638-2640	12	abstract	giv	coref	26-16
24-29	2641-2642	]	_	_	_	_

#Text=In 1978 , Frank led a team at Lehman Brothers , handling Humana 's acquisition of American Medicorp .
25-1	2643-2645	In	_	_	_	_
25-2	2646-2650	1978	time	new	_	_
25-3	2651-2652	,	_	_	_	_
25-4	2653-2658	Frank	person	giv	coref	27-1
25-5	2659-2662	led	_	_	_	_
25-6	2663-2664	a	organization[178]	new[178]	coref	26-1[184_178]
25-7	2665-2669	team	organization[178]	new[178]	_	_
25-8	2670-2672	at	organization[178]	new[178]	_	_
25-9	2673-2679	Lehman	organization[178]|person|person[180]	new[178]|giv|giv[180]	coref|coref	25-9[180_0]|27-9[0_180]
25-10	2680-2688	Brothers	organization[178]|person[180]	new[178]|giv[180]	_	_
25-11	2689-2690	,	_	_	_	_
25-12	2691-2699	handling	_	_	_	_
25-13	2700-2706	Humana	organization[181]|event[182]	new[181]|new[182]	_	_
25-14	2707-2709	's	organization[181]|event[182]	new[181]|new[182]	_	_
25-15	2710-2721	acquisition	event[182]	new[182]	_	_
25-16	2722-2724	of	event[182]	new[182]	_	_
25-17	2725-2733	American	event[182]|abstract[183]	new[182]|new[183]	_	_
25-18	2734-2742	Medicorp	event[182]|abstract[183]	new[182]|new[183]	_	_
25-19	2743-2744	.	_	_	_	_

#Text=The team included Mary Catherine Tanner , a recent graduate from Harvard University . [ 12 ]
26-1	2745-2748	The	organization[184]	giv[184]	coref	27-6[192_184]
26-2	2749-2753	team	organization[184]	giv[184]	_	_
26-3	2754-2762	included	_	_	_	_
26-4	2763-2767	Mary	person[185]	new[185]	appos	26-8[186_185]
26-5	2768-2777	Catherine	person[185]	new[185]	_	_
26-6	2778-2784	Tanner	person[185]	new[185]	_	_
26-7	2785-2786	,	_	_	_	_
26-8	2787-2788	a	person[186]	giv[186]	ana	27-3[0_186]
26-9	2789-2795	recent	person[186]	giv[186]	_	_
26-10	2796-2804	graduate	person[186]	giv[186]	_	_
26-11	2805-2809	from	person[186]	giv[186]	_	_
26-12	2810-2817	Harvard	person[186]|organization[187]	giv[186]|giv[187]	coref	49-18[347_187]
26-13	2818-2828	University	person[186]|organization[187]	giv[186]|giv[187]	_	_
26-14	2829-2830	.	_	_	_	_
26-15	2831-2832	[	_	_	_	_
26-16	2833-2835	12	abstract	giv	coref	33-13
26-17	2836-2837	]	_	_	_	_

#Text=Frank convinced her to join his team at Lehman .
27-1	2838-2843	Frank	person	giv	ana	27-6
27-2	2844-2853	convinced	_	_	_	_
27-3	2854-2857	her	person	giv	coref	30-1
27-4	2858-2860	to	_	_	_	_
27-5	2861-2865	join	_	_	_	_
27-6	2866-2869	his	person|organization[192]	giv|giv[192]	coref	29-1
27-7	2870-2874	team	organization[192]	giv[192]	_	_
27-8	2875-2877	at	organization[192]	giv[192]	_	_
27-9	2878-2884	Lehman	organization[192]|person	giv[192]|giv	coref	29-6
27-10	2885-2886	.	_	_	_	_

#Text=Ten years later , on October 15 , 1988 , they were married . [ 3 ]
28-1	2887-2890	Ten	time[194]	new[194]	coref	31-9[211_194]
28-2	2891-2896	years	time[194]	new[194]	_	_
28-3	2897-2902	later	_	_	_	_
28-4	2903-2904	,	_	_	_	_
28-5	2905-2907	on	_	_	_	_
28-6	2908-2915	October	time[195]	new[195]	coref	38-19[0_195]
28-7	2916-2918	15	time[195]	new[195]	_	_
28-8	2919-2920	,	time[195]	new[195]	_	_
28-9	2921-2925	1988	time[195]|time	new[195]|new	_	_
28-10	2926-2927	,	_	_	_	_
28-11	2928-2932	they	person	giv	_	_
28-12	2933-2937	were	_	_	_	_
28-13	2938-2945	married	_	_	_	_
28-14	2946-2947	.	_	_	_	_
28-15	2948-2949	[	_	_	_	_
28-16	2950-2951	3	abstract	giv	_	_
28-17	2952-2953	]	_	_	_	_

#Text=Frank became vice chair of Lehman Brothers in 1995 . [ 11 ]
29-1	2954-2959	Frank	person	giv	coref	31-1
29-2	2960-2966	became	_	_	_	_
29-3	2967-2971	vice	abstract	new	coref	39-4
29-4	2972-2977	chair	_	_	_	_
29-5	2978-2980	of	_	_	_	_
29-6	2981-2987	Lehman	person|person[202]	giv|giv[202]	coref|coref	29-6[202_0]|31-7[0_202]
29-7	2988-2996	Brothers	person[202]	giv[202]	_	_
29-8	2997-2999	in	_	_	_	_
29-9	3000-3004	1995	time	new	_	_
29-10	3005-3006	.	_	_	_	_
29-11	3007-3008	[	_	_	_	_
29-12	3009-3011	11	abstract	giv	coref	51-10
29-13	3012-3013	]	_	_	_	_

#Text=Tanner became senior managing director . [ 1 ]
30-1	3014-3020	Tanner	person	giv	coref	31-14
30-2	3021-3027	became	_	_	_	_
30-3	3028-3034	senior	_	_	_	_
30-4	3035-3043	managing	organization	new	coref	41-15
30-5	3044-3052	director	_	_	_	_
30-6	3053-3054	.	_	_	_	_
30-7	3055-3056	[	_	_	_	_
30-8	3057-3058	1	abstract	new	coref	34-9[232_0]
30-9	3059-3060	]	_	_	_	_

#Text=Frank and Tanner worked together at Lehman for over ten years , until Tanner took time off to have a child . [ 2 ]
31-1	3061-3066	Frank	person|person[209]	giv|giv[209]	coref|coref	31-1[209_0]|32-6[0_209]
31-2	3067-3070	and	person[209]	giv[209]	_	_
31-3	3071-3077	Tanner	person[209]	giv[209]	_	_
31-4	3078-3084	worked	_	_	_	_
31-5	3085-3093	together	_	_	_	_
31-6	3094-3096	at	_	_	_	_
31-7	3097-3103	Lehman	person	giv	coref	38-5[258_0]
31-8	3104-3107	for	_	_	_	_
31-9	3108-3112	over	time[211]	giv[211]	_	_
31-10	3113-3116	ten	time[211]	giv[211]	_	_
31-11	3117-3122	years	time[211]	giv[211]	_	_
31-12	3123-3124	,	_	_	_	_
31-13	3125-3130	until	_	_	_	_
31-14	3131-3137	Tanner	person	giv	coref	40-11[275_0]
31-15	3138-3142	took	_	_	_	_
31-16	3143-3147	time	_	_	_	_
31-17	3148-3151	off	_	_	_	_
31-18	3152-3154	to	_	_	_	_
31-19	3155-3159	have	_	_	_	_
31-20	3160-3161	a	person[213]	new[213]	_	_
31-21	3162-3167	child	person[213]	new[213]	_	_
31-22	3168-3169	.	_	_	_	_
31-23	3170-3171	[	_	_	_	_
31-24	3172-3173	2	abstract	new	_	_
31-25	3174-3175	]	_	_	_	_

#Text=In the late 1970s , Frank began to work with companies such as Cetus , a company developing industrial applications for Recombinant DNA technology , and Genentech .
32-1	3176-3178	In	_	_	_	_
32-2	3179-3182	the	time[215]	new[215]	_	_
32-3	3183-3187	late	time[215]	new[215]	_	_
32-4	3188-3193	1970s	time[215]	new[215]	_	_
32-5	3194-3195	,	_	_	_	_
32-6	3196-3201	Frank	person	giv	coref	33-1
32-7	3202-3207	began	_	_	_	_
32-8	3208-3210	to	_	_	_	_
32-9	3211-3215	work	_	_	_	_
32-10	3216-3220	with	_	_	_	_
32-11	3221-3230	companies	organization[217]	giv[217]	_	_
32-12	3231-3235	such	organization[217]	giv[217]	_	_
32-13	3236-3238	as	organization[217]	giv[217]	_	_
32-14	3239-3244	Cetus	organization[217]|organization	giv[217]|new	appos	32-16[219_0]
32-15	3245-3246	,	_	_	_	_
32-16	3247-3248	a	organization[219]	giv[219]	coref	34-5[0_219]
32-17	3249-3256	company	organization[219]	giv[219]	_	_
32-18	3257-3267	developing	organization[219]	giv[219]	_	_
32-19	3268-3278	industrial	organization[219]|abstract[220]	giv[219]|new[220]	_	_
32-20	3279-3291	applications	organization[219]|abstract[220]	giv[219]|new[220]	_	_
32-21	3292-3295	for	organization[219]|abstract[220]	giv[219]|new[220]	_	_
32-22	3296-3307	Recombinant	organization[219]|abstract[220]|object|abstract[223]	giv[219]|new[220]|new|new[223]	coref	33-3[227_223]
32-23	3308-3311	DNA	organization[219]|abstract[220]|abstract|abstract[223]	giv[219]|new[220]|new|new[223]	_	_
32-24	3312-3322	technology	organization[219]|abstract[220]|abstract[223]	giv[219]|new[220]|new[223]	_	_
32-25	3323-3324	,	_	_	_	_
32-26	3325-3328	and	_	_	_	_
32-27	3329-3338	Genentech	organization	new	coref	35-18
32-28	3339-3340	.	_	_	_	_

#Text=Frank saw rDNA technology as a " game-changing opportunity " . [ 12 ]
33-1	3341-3346	Frank	person	giv	coref	34-3
33-2	3347-3350	saw	_	_	_	_
33-3	3351-3355	rDNA	organization|abstract[227]	new|giv[227]	_	_
33-4	3356-3366	technology	abstract[227]	giv[227]	_	_
33-5	3367-3369	as	_	_	_	_
33-6	3370-3371	a	abstract[228]	new[228]	_	_
33-7	3372-3373	"	abstract[228]	new[228]	_	_
33-8	3374-3387	game-changing	abstract[228]	new[228]	_	_
33-9	3388-3399	opportunity	abstract[228]	new[228]	_	_
33-10	3400-3401	"	abstract[228]	new[228]	_	_
33-11	3402-3403	.	_	_	_	_
33-12	3404-3405	[	_	_	_	_
33-13	3406-3408	12	abstract	giv	coref	34-23
33-14	3409-3410	]	_	_	_	_

#Text=Advised by Frank , Cetus went public on March 1 , 1981 with the second-largest IPO in U.S. corporate history . [ 12 ]
34-1	3411-3418	Advised	_	_	_	_
34-2	3419-3421	by	_	_	_	_
34-3	3422-3427	Frank	person	giv	coref	35-1
34-4	3428-3429	,	_	_	_	_
34-5	3430-3435	Cetus	organization	giv	coref	36-8[248_0]
34-6	3436-3440	went	_	_	_	_
34-7	3441-3447	public	_	_	_	_
34-8	3448-3450	on	_	_	_	_
34-9	3451-3456	March	abstract[232]	giv[232]	_	_
34-10	3457-3458	1	abstract[232]	giv[232]	_	_
34-11	3459-3460	,	abstract[232]	giv[232]	_	_
34-12	3461-3465	1981	abstract[232]|time	giv[232]|new	_	_
34-13	3466-3470	with	_	_	_	_
34-14	3471-3474	the	abstract[234]	new[234]	_	_
34-15	3475-3489	second-largest	abstract[234]	new[234]	_	_
34-16	3490-3493	IPO	abstract[234]	new[234]	_	_
34-17	3494-3496	in	abstract[234]	new[234]	_	_
34-18	3497-3501	U.S.	abstract[234]|place|abstract[236]	new[234]|new|new[236]	coref	38-7
34-19	3502-3511	corporate	abstract[234]|abstract[236]	new[234]|new[236]	_	_
34-20	3512-3519	history	abstract[234]|abstract[236]	new[234]|new[236]	_	_
34-21	3520-3521	.	_	_	_	_
34-22	3522-3523	[	_	_	_	_
34-23	3524-3526	12	abstract	giv	coref	35-23
34-24	3527-3528	]	_	_	_	_

#Text=Frank was also instrumental in the Bristol-Myers Squibb merger of 1989 and the Hoffmann-La Roche acquisition of Genentech in 1990 . [ 12 ]
35-1	3529-3534	Frank	person	giv	coref	37-6
35-2	3535-3538	was	_	_	_	_
35-3	3539-3543	also	_	_	_	_
35-4	3544-3556	instrumental	_	_	_	_
35-5	3557-3559	in	_	_	_	_
35-6	3560-3563	the	event[240]	new[240]	_	_
35-7	3564-3577	Bristol-Myers	organization[239]|event[240]	new[239]|new[240]	_	_
35-8	3578-3584	Squibb	organization[239]|event[240]	new[239]|new[240]	_	_
35-9	3585-3591	merger	event[240]	new[240]	_	_
35-10	3592-3594	of	event[240]	new[240]	_	_
35-11	3595-3599	1989	event[240]|time	new[240]|new	_	_
35-12	3600-3603	and	_	_	_	_
35-13	3604-3607	the	event[243]	new[243]	_	_
35-14	3608-3619	Hoffmann-La	abstract[242]|event[243]	new[242]|new[243]	_	_
35-15	3620-3625	Roche	abstract[242]|event[243]	new[242]|new[243]	_	_
35-16	3626-3637	acquisition	event[243]	new[243]	_	_
35-17	3638-3640	of	event[243]	new[243]	_	_
35-18	3641-3650	Genentech	event[243]|organization	new[243]|giv	_	_
35-19	3651-3653	in	event[243]	new[243]	_	_
35-20	3654-3658	1990	event[243]|time	new[243]|new	_	_
35-21	3659-3660	.	_	_	_	_
35-22	3661-3662	[	_	_	_	_
35-23	3663-3665	12	abstract	giv	ana	37-1
35-24	3666-3667	]	_	_	_	_

#Text=At the time , the merger of an established pharmaceutical company with a younger biotechnology company was highly unusual .
36-1	3668-3670	At	_	_	_	_
36-2	3671-3674	the	_	_	_	_
36-3	3675-3679	time	_	_	_	_
36-4	3680-3681	,	_	_	_	_
36-5	3682-3685	the	event[247]	new[247]	_	_
36-6	3686-3692	merger	event[247]	new[247]	_	_
36-7	3693-3695	of	event[247]	new[247]	_	_
36-8	3696-3698	an	event[247]|organization[248]	new[247]|giv[248]	coref	36-13[250_248]
36-9	3699-3710	established	event[247]|organization[248]	new[247]|giv[248]	_	_
36-10	3711-3725	pharmaceutical	event[247]|organization[248]	new[247]|giv[248]	_	_
36-11	3726-3733	company	event[247]|organization[248]	new[247]|giv[248]	_	_
36-12	3734-3738	with	event[247]|organization[248]	new[247]|giv[248]	_	_
36-13	3739-3740	a	event[247]|organization[248]|organization[250]	new[247]|giv[248]|giv[250]	_	_
36-14	3741-3748	younger	event[247]|organization[248]|organization[250]	new[247]|giv[248]|giv[250]	_	_
36-15	3749-3762	biotechnology	event[247]|organization[248]|abstract|organization[250]	new[247]|giv[248]|new|giv[250]	_	_
36-16	3763-3770	company	event[247]|organization[248]|organization[250]	new[247]|giv[248]|giv[250]	_	_
36-17	3771-3774	was	_	_	_	_
36-18	3775-3781	highly	_	_	_	_
36-19	3782-3789	unusual	_	_	_	_
36-20	3790-3791	.	_	_	_	_

#Text=It has been described by Frank as a " strategy of convergence " . [ 13 ]
37-1	3792-3794	It	abstract	giv	_	_
37-2	3795-3798	has	_	_	_	_
37-3	3799-3803	been	_	_	_	_
37-4	3804-3813	described	_	_	_	_
37-5	3814-3816	by	_	_	_	_
37-6	3817-3822	Frank	person	giv	coref	39-1
37-7	3823-3825	as	_	_	_	_
37-8	3826-3827	a	abstract[253]	new[253]	_	_
37-9	3828-3829	"	abstract[253]	new[253]	_	_
37-10	3830-3838	strategy	abstract[253]	new[253]	_	_
37-11	3839-3841	of	abstract[253]	new[253]	_	_
37-12	3842-3853	convergence	abstract[253]|abstract	new[253]|new	_	_
37-13	3854-3855	"	abstract[253]	new[253]	_	_
37-14	3856-3857	.	_	_	_	_
37-15	3858-3859	[	_	_	_	_
37-16	3860-3862	13	abstract	new	_	_
37-17	3863-3864	]	_	_	_	_

#Text=After Barclays Capital bought Lehman 's U.S. capital markets unit in September 2008 , [ 14 ] [ 15 ]
38-1	3865-3870	After	_	_	_	_
38-2	3871-3879	Barclays	organization|organization[257]	giv|giv[257]	coref|coref	39-7|39-7[269_257]
38-3	3880-3887	Capital	organization[257]	giv[257]	_	_
38-4	3888-3894	bought	_	_	_	_
38-5	3895-3901	Lehman	person[258]|organization[261]	giv[258]|new[261]	_	_
38-6	3902-3904	's	person[258]|organization[261]	giv[258]|new[261]	_	_
38-7	3905-3909	U.S.	place|place[260]|organization[261]	giv|new[260]|new[261]	_	_
38-8	3910-3917	capital	place[260]|organization[261]	new[260]|new[261]	_	_
38-9	3918-3925	markets	place[260]|organization[261]	new[260]|new[261]	_	_
38-10	3926-3930	unit	organization[261]	new[261]	_	_
38-11	3931-3933	in	_	_	_	_
38-12	3934-3943	September	time[262]	new[262]	_	_
38-13	3944-3948	2008	time[262]|time	new[262]|new	_	_
38-14	3949-3950	,	_	_	_	_
38-15	3951-3952	[	_	_	_	_
38-16	3953-3955	14	abstract	new	_	_
38-17	3956-3957	]	_	_	_	_
38-18	3958-3959	[	_	_	_	_
38-19	3960-3962	15	time	giv	coref	42-3[289_0]
38-20	3963-3964	]	_	_	_	_

#Text=Frank became a vice chair at Barclays Capital . [ 16 ]
39-1	3965-3970	Frank	person	giv	coref	40-8[273_0]
39-2	3971-3977	became	_	_	_	_
39-3	3978-3979	a	_	_	_	_
39-4	3980-3984	vice	abstract	giv	coref	41-4
39-5	3985-3990	chair	_	_	_	_
39-6	3991-3993	at	_	_	_	_
39-7	3994-4002	Barclays	organization|organization[269]	giv|giv[269]	_	_
39-8	4003-4010	Capital	organization[269]	giv[269]	_	_
39-9	4011-4012	.	_	_	_	_
39-10	4013-4014	[	_	_	_	_
39-11	4015-4017	16	abstract	new	coref	40-34
39-12	4018-4019	]	_	_	_	_

#Text=As of March 18 , 2009 , Frederick Frank and Mary Tanner joined Peter J. Solomon , of PJ SOLOMON to form a new practice focusing on pharmaceuticals and life sciences . [ 16 ]
40-1	4020-4022	As	_	_	_	_
40-2	4023-4025	of	_	_	_	_
40-3	4026-4031	March	time[271]	new[271]	coref	42-19[0_271]
40-4	4032-4034	18	time[271]	new[271]	_	_
40-5	4035-4036	,	time[271]	new[271]	_	_
40-6	4037-4041	2009	time[271]|time	new[271]|new	coref	52-6
40-7	4042-4043	,	_	_	_	_
40-8	4044-4053	Frederick	person[273]|person[274]	giv[273]|giv[274]	coref|coref	40-8[274_273]|41-1[0_274]
40-9	4054-4059	Frank	person[273]|person[274]	giv[273]|giv[274]	_	_
40-10	4060-4063	and	person[274]	giv[274]	_	_
40-11	4064-4068	Mary	person[274]|person[275]	giv[274]|giv[275]	coref	41-12[0_275]
40-12	4069-4075	Tanner	person[274]|person[275]	giv[274]|giv[275]	_	_
40-13	4076-4082	joined	_	_	_	_
40-14	4083-4088	Peter	person[276]	giv[276]	coref	41-7[285_276]
40-15	4089-4091	J.	person[276]	giv[276]	_	_
40-16	4092-4099	Solomon	person[276]	giv[276]	_	_
40-17	4100-4101	,	person[276]	giv[276]	_	_
40-18	4102-4104	of	person[276]	giv[276]	_	_
40-19	4105-4107	PJ	person[276]|organization[277]	giv[276]|new[277]	_	_
40-20	4108-4115	SOLOMON	person[276]|organization[277]	giv[276]|new[277]	_	_
40-21	4116-4118	to	_	_	_	_
40-22	4119-4123	form	_	_	_	_
40-23	4124-4125	a	organization[278]	new[278]	_	_
40-24	4126-4129	new	organization[278]	new[278]	_	_
40-25	4130-4138	practice	organization[278]	new[278]	_	_
40-26	4139-4147	focusing	organization[278]	new[278]	_	_
40-27	4148-4150	on	organization[278]	new[278]	_	_
40-28	4151-4166	pharmaceuticals	organization[278]|substance	new[278]|new	_	_
40-29	4167-4170	and	organization[278]	new[278]	_	_
40-30	4171-4175	life	organization[278]|abstract|abstract[281]	new[278]|giv|giv[281]	_	_
40-31	4176-4184	sciences	organization[278]|abstract[281]	new[278]|giv[281]	_	_
40-32	4185-4186	.	_	_	_	_
40-33	4187-4188	[	_	_	_	_
40-34	4189-4191	16	abstract	giv	_	_
40-35	4192-4193	]	_	_	_	_

#Text=Frank became a vice chairman at Peter J. Solomon , while Tanner became a managing director . [ 17 ]
41-1	4194-4199	Frank	person	giv	coref	42-8[291_0]
41-2	4200-4206	became	_	_	_	_
41-3	4207-4208	a	_	_	_	_
41-4	4209-4213	vice	abstract	giv	_	_
41-5	4214-4222	chairman	_	_	_	_
41-6	4223-4225	at	_	_	_	_
41-7	4226-4231	Peter	person[285]	giv[285]	_	_
41-8	4232-4234	J.	person[285]	giv[285]	_	_
41-9	4235-4242	Solomon	person[285]	giv[285]	_	_
41-10	4243-4244	,	_	_	_	_
41-11	4245-4250	while	_	_	_	_
41-12	4251-4257	Tanner	person	giv	coref	42-11[293_0]
41-13	4258-4264	became	_	_	_	_
41-14	4265-4266	a	_	_	_	_
41-15	4267-4275	managing	organization	giv	coref	44-5
41-16	4276-4284	director	_	_	_	_
41-17	4285-4286	.	_	_	_	_
41-18	4287-4288	[	_	_	_	_
41-19	4289-4291	17	abstract	new	_	_
41-20	4292-4293	]	_	_	_	_

#Text=As of January 15 , 2013 , Frederick Frank and Mary Tanner joined Burrill & Company . [ 18 ]
42-1	4294-4296	As	_	_	_	_
42-2	4297-4299	of	_	_	_	_
42-3	4300-4307	January	time[289]	giv[289]	_	_
42-4	4308-4310	15	time[289]	giv[289]	_	_
42-5	4311-4312	,	time[289]	giv[289]	_	_
42-6	4313-4317	2013	time[289]|time	giv[289]|new	_	_
42-7	4318-4319	,	_	_	_	_
42-8	4320-4329	Frederick	person[291]|person[292]	giv[291]|giv[292]	coref|coref	42-8[292_291]|43-1[0_292]
42-9	4330-4335	Frank	person[291]|person[292]	giv[291]|giv[292]	_	_
42-10	4336-4339	and	person[292]	giv[292]	_	_
42-11	4340-4344	Mary	person[292]|person[293]	giv[292]|giv[293]	coref	44-1[0_293]
42-12	4345-4351	Tanner	person[292]|person[293]	giv[292]|giv[293]	_	_
42-13	4352-4358	joined	_	_	_	_
42-14	4359-4366	Burrill	person|person[295]	new|new[295]	coref|coref	43-5|43-14[304_295]
42-15	4367-4368	&	person[295]	new[295]	_	_
42-16	4369-4376	Company	person[295]	new[295]	_	_
42-17	4377-4378	.	_	_	_	_
42-18	4379-4380	[	_	_	_	_
42-19	4381-4383	18	time	giv	coref	44-17
42-20	4384-4385	]	_	_	_	_

#Text=Frank became chair of Burrill Securities ( 2013- ) and vice chair of Burrill and Company ( January 15 , 2013- ) . [ 19 ]
43-1	4386-4391	Frank	person	giv	coref	45-5
43-2	4392-4398	became	_	_	_	_
43-3	4399-4404	chair	_	_	_	_
43-4	4405-4407	of	_	_	_	_
43-5	4408-4415	Burrill	person|organization[299]|organization[300]	giv|new[299]|new[300]	coref|coref	43-14|44-8[313_300]
43-6	4416-4426	Securities	organization[299]|organization[300]	new[299]|new[300]	_	_
43-7	4427-4428	(	organization[299]|organization[300]	new[299]|new[300]	_	_
43-8	4429-4434	2013-	organization[299]|organization[300]|time	new[299]|new[300]|new	coref	43-21
43-9	4435-4436	)	organization[299]|organization[300]	new[299]|new[300]	_	_
43-10	4437-4440	and	organization[300]	new[300]	_	_
43-11	4441-4445	vice	organization[300]|person[302]	new[300]|new[302]	_	_
43-12	4446-4451	chair	organization[300]|person[302]	new[300]|new[302]	_	_
43-13	4452-4454	of	organization[300]|person[302]	new[300]|new[302]	_	_
43-14	4455-4462	Burrill	organization[300]|person[302]|person|person[304]	new[300]|new[302]|giv|giv[304]	coref|coref	44-8|44-12[315_304]
43-15	4463-4466	and	organization[300]|person[302]|person[304]	new[300]|new[302]|giv[304]	_	_
43-16	4467-4474	Company	organization[300]|person[302]|person[304]|organization[305]	new[300]|new[302]|giv[304]|giv[305]	coref	45-19[325_305]
43-17	4475-4476	(	organization[300]|person[302]|person[304]|organization[305]	new[300]|new[302]|giv[304]|giv[305]	_	_
43-18	4477-4484	January	organization[300]|person[302]|person[304]|organization[305]|time	new[300]|new[302]|giv[304]|giv[305]|new	_	_
43-19	4485-4487	15	organization[300]|person[302]|person[304]|organization[305]	new[300]|new[302]|giv[304]|giv[305]	_	_
43-20	4488-4489	,	organization[300]|person[302]|person[304]|organization[305]	new[300]|new[302]|giv[304]|giv[305]	_	_
43-21	4490-4495	2013-	organization[300]|person[302]|person[304]|organization[305]|time	new[300]|new[302]|giv[304]|giv[305]|giv	_	_
43-22	4496-4497	)	organization[300]|person[302]|person[304]|organization[305]	new[300]|new[302]|giv[304]|giv[305]	_	_
43-23	4498-4499	.	_	_	_	_
43-24	4500-4501	[	_	_	_	_
43-25	4502-4504	19	abstract	new	coref	46-15
43-26	4505-4506	]	_	_	_	_

#Text=Tanner became the Senior Managing Director of Burrill Securities and of Burrill & Company . [ 18 ]
44-1	4507-4513	Tanner	person	giv	coref	48-9
44-2	4514-4520	became	_	_	_	_
44-3	4521-4524	the	person[311]	new[311]	_	_
44-4	4525-4531	Senior	person[311]	new[311]	_	_
44-5	4532-4540	Managing	organization|person[311]	giv|new[311]	_	_
44-6	4541-4549	Director	person[311]	new[311]	_	_
44-7	4550-4552	of	person[311]	new[311]	_	_
44-8	4553-4560	Burrill	person[311]|person|organization[313]	new[311]|giv|giv[313]	coref	44-12
44-9	4561-4571	Securities	person[311]|organization[313]	new[311]|giv[313]	_	_
44-10	4572-4575	and	_	_	_	_
44-11	4576-4578	of	_	_	_	_
44-12	4579-4586	Burrill	person|person[315]	giv|giv[315]	_	_
44-13	4587-4588	&	person[315]	giv[315]	_	_
44-14	4589-4596	Company	person[315]	giv[315]	_	_
44-15	4597-4598	.	_	_	_	_
44-16	4599-4600	[	_	_	_	_
44-17	4601-4603	18	time	giv	_	_
44-18	4604-4605	]	_	_	_	_

#Text=As of 2014 , Frank and Tanner founded EVOLUTION Life Science Partners , and Frank became chair of the company . [ 4 ]
45-1	4606-4608	As	_	_	_	_
45-2	4609-4611	of	_	_	_	_
45-3	4612-4616	2014	time	new	_	_
45-4	4617-4618	,	_	_	_	_
45-5	4619-4624	Frank	person|person[319]	giv|giv[319]	coref|coref	45-5[319_0]|45-15[0_319]
45-6	4625-4628	and	person[319]	giv[319]	_	_
45-7	4629-4635	Tanner	person[319]	giv[319]	_	_
45-8	4636-4643	founded	_	_	_	_
45-9	4644-4653	EVOLUTION	organization|organization[322]|organization[323]	giv|giv[322]|giv[323]	coref	58-11[0_322]
45-10	4654-4658	Life	person|organization[322]|organization[323]	giv|giv[322]|giv[323]	_	_
45-11	4659-4666	Science	organization[322]|organization[323]	giv[322]|giv[323]	_	_
45-12	4667-4675	Partners	organization[323]	giv[323]	_	_
45-13	4676-4677	,	_	_	_	_
45-14	4678-4681	and	_	_	_	_
45-15	4682-4687	Frank	person	giv	coref	46-1
45-16	4688-4694	became	_	_	_	_
45-17	4695-4700	chair	_	_	_	_
45-18	4701-4703	of	_	_	_	_
45-19	4704-4707	the	organization[325]	giv[325]	_	_
45-20	4708-4715	company	organization[325]	giv[325]	_	_
45-21	4716-4717	.	_	_	_	_
45-22	4718-4719	[	_	_	_	_
45-23	4720-4721	4	abstract	giv	coref	55-12
45-24	4722-4723	]	_	_	_	_

#Text=Frank has also served on numerous advisory groups and boards of directors . [ 19 ]
46-1	4724-4729	Frank	person	giv	coref	48-10
46-2	4730-4733	has	_	_	_	_
46-3	4734-4738	also	_	_	_	_
46-4	4739-4745	served	_	_	_	_
46-5	4746-4748	on	_	_	_	_
46-6	4749-4757	numerous	organization[328]	new[328]	_	_
46-7	4758-4766	advisory	organization[328]	new[328]	_	_
46-8	4767-4773	groups	organization[328]	new[328]	_	_
46-9	4774-4777	and	_	_	_	_
46-10	4778-4784	boards	organization[329]	new[329]	_	_
46-11	4785-4787	of	organization[329]	new[329]	_	_
46-12	4788-4797	directors	organization[329]|person	new[329]|new	_	_
46-13	4798-4799	.	_	_	_	_
46-14	4800-4801	[	_	_	_	_
46-15	4802-4804	19	abstract	giv	coref	56-13
46-16	4805-4806	]	_	_	_	_

#Text=Philanthropy
47-1	4807-4819	Philanthropy	person	new	_	_

#Text=As of October , 1997 , the non-profit Tanner Frank Foundation of New York City was granted charitable status . [ 20 ]
48-1	4820-4822	As	_	_	_	_
48-2	4823-4825	of	_	_	_	_
48-3	4826-4833	October	time[333]	giv[333]	appos	48-5[0_333]
48-4	4834-4835	,	time[333]	giv[333]	_	_
48-5	4836-4840	1997	time[333]|time	giv[333]|giv	coref	60-1
48-6	4841-4842	,	_	_	_	_
48-7	4843-4846	the	organization[337]	new[337]	_	_
48-8	4847-4857	non-profit	organization[337]	new[337]	_	_
48-9	4858-4864	Tanner	person|organization[337]	giv|new[337]	_	_
48-10	4865-4870	Frank	person|organization[337]	giv|new[337]	coref	49-1
48-11	4871-4881	Foundation	organization[337]	new[337]	_	_
48-12	4882-4884	of	organization[337]	new[337]	_	_
48-13	4885-4888	New	organization[337]|place[338]	new[337]|giv[338]	coref	56-7[384_338]
48-14	4889-4893	York	organization[337]|place[338]	new[337]|giv[338]	_	_
48-15	4894-4898	City	organization[337]|place[338]	new[337]|giv[338]	_	_
48-16	4899-4902	was	_	_	_	_
48-17	4903-4910	granted	_	_	_	_
48-18	4911-4921	charitable	abstract[339]	new[339]	_	_
48-19	4922-4928	status	abstract[339]	new[339]	_	_
48-20	4929-4930	.	_	_	_	_
48-21	4931-4932	[	_	_	_	_
48-22	4933-4935	20	abstract	new	_	_
48-23	4936-4937	]	_	_	_	_

#Text=Frank has served on the board of advisors of the School of Management ( SOM ) at Yale University , and has given generously to SOM .
49-1	4938-4943	Frank	person	giv	coref	53-13[371_0]
49-2	4944-4947	has	_	_	_	_
49-3	4948-4954	served	_	_	_	_
49-4	4955-4957	on	_	_	_	_
49-5	4958-4961	the	organization[342]	new[342]	_	_
49-6	4962-4967	board	organization[342]	new[342]	_	_
49-7	4968-4970	of	organization[342]	new[342]	_	_
49-8	4971-4979	advisors	organization[342]|person[343]	new[342]|new[343]	_	_
49-9	4980-4982	of	organization[342]|person[343]	new[342]|new[343]	_	_
49-10	4983-4986	the	organization[342]|person[343]|organization[344]	new[342]|new[343]|new[344]	_	_
49-11	4987-4993	School	organization[342]|person[343]|organization[344]	new[342]|new[343]|new[344]	_	_
49-12	4994-4996	of	organization[342]|person[343]|organization[344]	new[342]|new[343]|new[344]	_	_
49-13	4997-5007	Management	organization[342]|person[343]|organization[344]|person	new[342]|new[343]|new[344]|new	_	_
49-14	5008-5009	(	organization[342]|person[343]|organization[344]	new[342]|new[343]|new[344]	_	_
49-15	5010-5013	SOM	organization[342]|person[343]|organization[344]|organization	new[342]|new[343]|new[344]|new	coref	49-26
49-16	5014-5015	)	organization[342]|person[343]|organization[344]	new[342]|new[343]|new[344]	_	_
49-17	5016-5018	at	organization[342]|person[343]|organization[344]	new[342]|new[343]|new[344]	_	_
49-18	5019-5023	Yale	organization[342]|person[343]|organization[344]|organization[347]	new[342]|new[343]|new[344]|giv[347]	_	_
49-19	5024-5034	University	organization[342]|person[343]|organization[344]|organization[347]	new[342]|new[343]|new[344]|giv[347]	_	_
49-20	5035-5036	,	_	_	_	_
49-21	5037-5040	and	_	_	_	_
49-22	5041-5044	has	_	_	_	_
49-23	5045-5050	given	_	_	_	_
49-24	5051-5061	generously	_	_	_	_
49-25	5062-5064	to	_	_	_	_
49-26	5065-5068	SOM	organization	giv	_	_
49-27	5069-5070	.	_	_	_	_

#Text=Gifts include the establishment of a language study fellowship and a visiting professorship in 1998 .
50-1	5071-5076	Gifts	abstract	new	_	_
50-2	5077-5084	include	_	_	_	_
50-3	5085-5088	the	event[350]	new[350]	_	_
50-4	5089-5102	establishment	event[350]	new[350]	_	_
50-5	5103-5105	of	event[350]	new[350]	_	_
50-6	5106-5107	a	event[350]|abstract[353]	new[350]|new[353]	_	_
50-7	5108-5116	language	event[350]|abstract|abstract[352]|abstract[353]	new[350]|new|new[352]|new[353]	_	_
50-8	5117-5122	study	event[350]|abstract[352]|abstract[353]	new[350]|new[352]|new[353]	_	_
50-9	5123-5133	fellowship	event[350]|abstract[353]	new[350]|new[353]	_	_
50-10	5134-5137	and	event[350]	new[350]	_	_
50-11	5138-5139	a	event[350]|person[354]	new[350]|new[354]	ana	51-4[0_354]
50-12	5140-5148	visiting	event[350]|person[354]	new[350]|new[354]	_	_
50-13	5149-5162	professorship	event[350]|person[354]	new[350]|new[354]	_	_
50-14	5163-5165	in	event[350]|person[354]	new[350]|new[354]	_	_
50-15	5166-5170	1998	event[350]|person[354]|time	new[350]|new[354]|new	coref	59-1
50-16	5171-5172	.	_	_	_	_

#Text=In 2007 , he established a professorship , [ 11 ]
51-1	5173-5175	In	_	_	_	_
51-2	5176-5180	2007	time	new	_	_
51-3	5181-5182	,	_	_	_	_
51-4	5183-5185	he	person	giv	coref	51-6[358_0]
51-5	5186-5197	established	_	_	_	_
51-6	5198-5199	a	person[358]	giv[358]	_	_
51-7	5200-5213	professorship	person[358]	giv[358]	_	_
51-8	5214-5215	,	_	_	_	_
51-9	5216-5217	[	_	_	_	_
51-10	5218-5220	11	abstract	giv	_	_
51-11	5221-5222	]	_	_	_	_

#Text=which was first filled in 2009 when Gary Gorton became Yale 's first Frederick Frank Class of 1954 Professor of Management and Finance . [ 21 ]
52-1	5223-5228	which	_	_	_	_
52-2	5229-5232	was	_	_	_	_
52-3	5233-5238	first	_	_	_	_
52-4	5239-5245	filled	_	_	_	_
52-5	5246-5248	in	_	_	_	_
52-6	5249-5253	2009	time	giv	_	_
52-7	5254-5258	when	_	_	_	_
52-8	5259-5263	Gary	person[361]	new[361]	_	_
52-9	5264-5270	Gorton	person[361]	new[361]	_	_
52-10	5271-5277	became	_	_	_	_
52-11	5278-5282	Yale	place[362]|person[364]	new[362]|new[364]	_	_
52-12	5283-5285	's	place[362]|person[364]	new[362]|new[364]	_	_
52-13	5286-5291	first	person[364]	new[364]	_	_
52-14	5292-5301	Frederick	person[364]	new[364]	_	_
52-15	5302-5307	Frank	person[364]	new[364]	_	_
52-16	5308-5313	Class	person[364]	new[364]	_	_
52-17	5314-5316	of	person[364]	new[364]	_	_
52-18	5317-5321	1954	time|person[364]	giv|new[364]	_	_
52-19	5322-5331	Professor	person[364]	new[364]	_	_
52-20	5332-5334	of	person[364]	new[364]	_	_
52-21	5335-5345	Management	person[364]|abstract	new[364]|new	coref	53-19
52-22	5346-5349	and	person[364]	new[364]	_	_
52-23	5350-5357	Finance	person[364]|organization	new[364]|new	_	_
52-24	5358-5359	.	_	_	_	_
52-25	5360-5361	[	_	_	_	_
52-26	5362-5364	21	abstract	new	_	_
52-27	5365-5366	]	_	_	_	_

#Text=On April 9 , 2012 Olav Sorenson became the inaugural holder of the Frank and Tanner Professor of Management . [ 22 ]
53-1	5367-5369	On	_	_	_	_
53-2	5370-5375	April	time[368]	new[368]	_	_
53-3	5376-5377	9	time[368]	new[368]	_	_
53-4	5378-5379	,	time[368]	new[368]	_	_
53-5	5380-5384	2012	time[368]|time	new[368]|new	_	_
53-6	5385-5389	Olav	person[370]	new[370]	_	_
53-7	5390-5398	Sorenson	person[370]	new[370]	_	_
53-8	5399-5405	became	_	_	_	_
53-9	5406-5409	the	_	_	_	_
53-10	5410-5419	inaugural	_	_	_	_
53-11	5420-5426	holder	_	_	_	_
53-12	5427-5429	of	_	_	_	_
53-13	5430-5433	the	person[371]	giv[371]	_	_
53-14	5434-5439	Frank	person[371]	giv[371]	_	_
53-15	5440-5443	and	person[371]	giv[371]	_	_
53-16	5444-5450	Tanner	person[371]	giv[371]	_	_
53-17	5451-5460	Professor	person[371]	giv[371]	_	_
53-18	5461-5463	of	person[371]	giv[371]	_	_
53-19	5464-5474	Management	person[371]|abstract	giv[371]|giv	_	_
53-20	5475-5476	.	_	_	_	_
53-21	5477-5478	[	_	_	_	_
53-22	5479-5481	22	abstract	new	_	_
53-23	5482-5483	]	_	_	_	_

#Text=Awards and honors
54-1	5484-5490	Awards	abstract	new	_	_
54-2	5491-5494	and	_	_	_	_
54-3	5495-5501	honors	abstract	new	_	_

#Text=2019 , Richard J. Bolte Sr. Award for supporting industries [ 4 ]
55-1	5502-5506	2019	_	_	_	_
55-2	5507-5508	,	_	_	_	_
55-3	5509-5516	Richard	person[376]|abstract[378]	new[376]|new[378]	coref	56-1[386_378]
55-4	5517-5519	J.	person[376]|abstract[378]	new[376]|new[378]	_	_
55-5	5520-5525	Bolte	person[376]|abstract[378]	new[376]|new[378]	_	_
55-6	5526-5529	Sr.	person|abstract[378]	new|new[378]	_	_
55-7	5530-5535	Award	abstract[378]	new[378]	_	_
55-8	5536-5539	for	abstract[378]	new[378]	_	_
55-9	5540-5550	supporting	abstract[378]|abstract[379]	new[378]|new[379]	_	_
55-10	5551-5561	industries	abstract[378]|abstract[379]	new[378]|new[379]	_	_
55-11	5562-5563	[	_	_	_	_
55-12	5564-5565	4	abstract	giv	_	_
55-13	5566-5567	]	_	_	_	_

#Text=2006 , Gilda 's Club of New York City Visionary Award [ 19 ]
56-1	5568-5572	2006	time|abstract[386]	new|giv[386]	coref	58-1[395_386]
56-2	5573-5574	,	abstract[386]	giv[386]	_	_
56-3	5575-5580	Gilda	person[382]|organization[383]|abstract[386]	new[382]|new[383]|giv[386]	_	_
56-4	5581-5583	's	person[382]|organization[383]|abstract[386]	new[382]|new[383]|giv[386]	_	_
56-5	5584-5588	Club	organization[383]|abstract[386]	new[383]|giv[386]	_	_
56-6	5589-5591	of	organization[383]|abstract[386]	new[383]|giv[386]	_	_
56-7	5592-5595	New	organization[383]|place[384]|abstract[386]	new[383]|giv[384]|giv[386]	_	_
56-8	5596-5600	York	organization[383]|place[384]|abstract[386]	new[383]|giv[384]|giv[386]	_	_
56-9	5601-5605	City	organization[383]|place[384]|abstract[386]	new[383]|giv[384]|giv[386]	_	_
56-10	5606-5615	Visionary	person|abstract[386]	new|giv[386]	_	_
56-11	5616-5621	Award	abstract[386]	giv[386]	_	_
56-12	5622-5623	[	_	_	_	_
56-13	5624-5626	19	abstract	giv	coref	58-13
56-14	5627-5628	]	_	_	_	_

#Text=2005 , Top 100 living contributors to biotechnology , Reed Elsevier [ 5 ]
57-1	5629-5633	2005	time|person[389]	new|new[389]	_	_
57-2	5634-5635	,	person[389]	new[389]	_	_
57-3	5636-5639	Top	person[389]	new[389]	_	_
57-4	5640-5643	100	person[389]	new[389]	_	_
57-5	5644-5650	living	person[389]	new[389]	_	_
57-6	5651-5663	contributors	person[389]	new[389]	_	_
57-7	5664-5666	to	person[389]	new[389]	_	_
57-8	5667-5680	biotechnology	person[389]|abstract	new[389]|new	_	_
57-9	5681-5682	,	_	_	_	_
57-10	5683-5687	Reed	person	new	_	_
57-11	5688-5696	Elsevier	_	_	_	_
57-12	5697-5698	[	_	_	_	_
57-13	5699-5700	5	abstract	giv	coref	59-20
57-14	5701-5702	]	_	_	_	_

#Text=2004 , Albert Einstein Award from the Weizmann Institute of Science [ 19 ]
58-1	5703-5707	2004	time|abstract[395]	new|giv[395]	coref	60-1[412_395]
58-2	5708-5709	,	abstract[395]	giv[395]	_	_
58-3	5710-5716	Albert	person[394]|abstract[395]	new[394]|giv[395]	_	_
58-4	5717-5725	Einstein	person[394]|abstract[395]	new[394]|giv[395]	_	_
58-5	5726-5731	Award	abstract[395]	giv[395]	_	_
58-6	5732-5736	from	abstract[395]	giv[395]	_	_
58-7	5737-5740	the	abstract[395]|organization[397]	giv[395]|new[397]	coref	59-11[405_397]
58-8	5741-5749	Weizmann	abstract[395]|person|organization[397]	giv[395]|new|new[397]	_	_
58-9	5750-5759	Institute	abstract[395]|organization[397]	giv[395]|new[397]	_	_
58-10	5760-5762	of	abstract[395]|organization[397]	giv[395]|new[397]	_	_
58-11	5763-5770	Science	abstract[395]|organization[397]|organization	giv[395]|new[397]|giv	_	_
58-12	5771-5772	[	_	_	_	_
58-13	5773-5775	19	abstract	giv	coref	59-17
58-14	5776-5777	]	_	_	_	_

#Text=1998 , Outstanding Contributions in the Field of Immunology , Irvington Institute for Immunological Research [ 19 ] [ 5 ]
59-1	5778-5782	1998	time|abstract[401]	giv|new[401]	_	_
59-2	5783-5784	,	abstract[401]	new[401]	_	_
59-3	5785-5796	Outstanding	abstract[401]	new[401]	_	_
59-4	5797-5810	Contributions	abstract[401]	new[401]	_	_
59-5	5811-5813	in	abstract[401]	new[401]	_	_
59-6	5814-5817	the	abstract[401]|abstract[402]	new[401]|new[402]	_	_
59-7	5818-5823	Field	abstract[401]|abstract[402]	new[401]|new[402]	_	_
59-8	5824-5826	of	abstract[401]|abstract[402]	new[401]|new[402]	_	_
59-9	5827-5837	Immunology	abstract[401]|abstract[402]|person	new[401]|new[402]|new	_	_
59-10	5838-5839	,	_	_	_	_
59-11	5840-5849	Irvington	place|organization[405]	new|giv[405]	_	_
59-12	5850-5859	Institute	organization[405]	giv[405]	_	_
59-13	5860-5863	for	organization[405]	giv[405]	_	_
59-14	5864-5877	Immunological	organization[405]|abstract|abstract[407]	giv[405]|new|new[407]	_	_
59-15	5878-5886	Research	organization[405]|abstract[407]	giv[405]|new[407]	_	_
59-16	5887-5888	[	_	_	_	_
59-17	5889-5891	19	abstract	giv	_	_
59-18	5892-5893	]	_	_	_	_
59-19	5894-5895	[	_	_	_	_
59-20	5896-5897	5	abstract	giv	coref	60-18
59-21	5898-5899	]	_	_	_	_

#Text=1997 , Hall of Fame Award , The Biotech Meeting in Laguna Niguel , California . [ 5 ] [ 6 ]
60-1	5900-5904	1997	time|abstract[412]	giv|giv[412]	_	_
60-2	5905-5906	,	abstract[412]	giv[412]	_	_
60-3	5907-5911	Hall	organization[411]|abstract[412]	new[411]|giv[412]	_	_
60-4	5912-5914	of	organization[411]|abstract[412]	new[411]|giv[412]	_	_
60-5	5915-5919	Fame	organization[411]|abstract[412]	new[411]|giv[412]	_	_
60-6	5920-5925	Award	abstract[412]	giv[412]	_	_
60-7	5926-5927	,	_	_	_	_
60-8	5928-5931	The	event[414]	new[414]	_	_
60-9	5932-5939	Biotech	place|event[414]	new|new[414]	_	_
60-10	5940-5947	Meeting	event[414]	new[414]	_	_
60-11	5948-5950	in	event[414]	new[414]	_	_
60-12	5951-5957	Laguna	event[414]|place|time[416]	new[414]|new|new[416]	_	_
60-13	5958-5964	Niguel	event[414]|time[416]	new[414]|new[416]	_	_
60-14	5965-5966	,	event[414]|time[416]	new[414]|new[416]	_	_
60-15	5967-5977	California	event[414]|time[416]|place	new[414]|new[416]|new	_	_
60-16	5978-5979	.	_	_	_	_
60-17	5980-5981	[	_	_	_	_
60-18	5982-5983	5	abstract	giv	_	_
60-19	5984-5985	]	_	_	_	_
60-20	5986-5987	[	_	_	_	_
60-21	5988-5989	6	abstract	new	_	_
60-22	5990-5991	]	_	_	_	_
